comparemela.com

Latest Breaking News On - Marvel biotechnology inc - Page 4 : comparemela.com

Marvel Biosciences Corp.: Marvel Biosciences Announces Proposed Debenture Offering

Calgary, Alberta (Newsfile Corp. - February 15, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) ("Marvel" or the "Company") announced today its intention to complete a non-brokered private placement offering

Dennis-riedl
Mark-williams
Good-lab-practice
Marvel-biosciences-corp
Marvel-biotechnology-inc
Virtus-advisory-group
Company-common
Alberta-newsfile-corp
Regulation-services-provider
Venture-exchange
Common-shares
Common-share

Marvel Biosciences Corp.: Marvel Biosciences Completes a Critical Manufacturing Milestone Required to Enter Phase 1 Human Trials Targeting Alzheimer's Disease and Depression

Calgary, Alberta (Newsfile Corp. - January 6, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company " or "Marvel "), are

United-states
Canada
Calgary
Alberta
Canadian
Kostenloser-wertpapierhandel
Mark-williams
Zhejiang-ausun-pharmaceutical-co-ltd
Marvel-biosciences-corp
Marvel-biotechnology-inc
Virtus-advisory-group
Alberta-newsfile-corp

vimarsana © 2020. All Rights Reserved.